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Abstract: Despite the great advances in cancer treatment, colorectal cancer has emerged as the second
highest cause of death from cancer worldwide. For this type of tumor, the use of suicide gene therapy
could represent a novel therapy. We recently demonstrated that co-expression of gef and apoptin
dramatically inhibits proliferation of the DLD-1 colon cell line. In the present manuscript, we try to
establish the mechanism underlying the enhanced induction of apoptosis by triggering both gef and
apoptin expression in colon tumor cells. Scanning microscopy reveals that simultaneous expression of
gef and apoptin induces the apparition of many “pores” in the cytoplasmic membrane not detected
in control cell lines. The formation of pores induced by the gef gene and accentuated by apoptin
results in cell death by necrosis. Moreover, we observed the presence of apoptotic cells. Performing
protein expression analysis using western blot, we revealed an activation of mitochondrial apoptosis
(increased expression of Pp53, cytochrome c, Bax, and caspase 9) and also the involvement of the
extrinsic pathway through caspase 8activation. In conclusion, in this manuscript we demonstrate for
the first time that the extrinsic pathway of apoptosis and pore formation is also involved in the cell
death caused by the co-expression of the gef and apoptin genes. Our results suggest that co-expression
of gef and apoptin genes induces an increase in post-apoptotic necrotic cell death and could be a
valuable tool in the design of new antitumor strategies focused on the enhancement of the immune
response against cancer cell death.
Keywords: gef gene; apoptin gene; combined therapy; apoptosis; caspase 3; caspase 8; caspase 9;
necrosis; pore
1. Introduction
Colorectal cancer is known to be the second most frequent cause of cancer death and the third in
terms of incidence for both sexes combined. The estimation of new colorectal cancer cases in 2018 is over
1.8 million, and 881,000 patients are estimated to have died in 2018. These numbers represent about 1
out of 10 cancer deaths by this disease [1]. Surgical resection is the first-line treatment for localized
early-stage colon cancer and adjuvant therapy is mainly used for high-risk colon cancer patients to
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increase the chance of cure. While multimodality therapies are a potential cure for low-metastatic
liver and lung risk patients, palliative systemic therapy is aimed at improving the quality of life of
non-surgical colon cancer candidates, prolonging the life expectancy of these patients. Drug resistance
develops in almost all patients with colon cancer, which leads to a decrease in the therapeutic efficacy
of anticancer agents and the urgent need for new alternative treatments [2,3]. The use of gene therapy
aimed at delivering genetic material to cancer cells for therapeutic purposes seems to be a good
alternative [4].
The use of toxic proteins encoded by killer genes delivered to cancer cells have been proposed as a
promising tool for antitumor gene therapy. The main advantage of using these proteins is the ability to
kill even quiescent tumor cells, while the classic genes used in conventional suicide gene therapy only
target rapidly dividing cells by disrupting the DNA synthesis. Numerous suicide genes of different
viruses, bacteria, and plants have been successfully used as a tool for this purpose in experiments
aimed at killing cancer cells [5,6]. The anticancer effect of the toxin streptolysin O secreted by bacteria
from the genus Streptococcus has been described both in vitro and in vivo [5,7]. Diphtheria toxin, ricin
derived from plants, and pseudomonas exotoxin have an effective ADP-ribosylate elongation factor 2,
and therefore, block the translation machinery of target cells and induce potent cell death. The potential
use of this toxin to eradicate tumoral cells has been tested in different experiments [8–11]. The ability
of Apoptin, a small protein encoded by chicken anemia virus to target selectively tumoral cells with
no effect on normal cells (i.e., melanoma, hepatoma, different types of colon cancer, osteosarcoma,
and cancers of breast, colon, prostate, lung, stomach, and cervix, among others) [12] could be used to
induce apoptosis in cancer cells. Another candidate to be used is the gef gene. This gene expressed
in E. coli encodes small and toxic proteins of approximately 50 amino acids that are able to induce
apoptosis, cell cycle arrest, and the apparition of morphologic changes in a variety of human cancer
cells [13–15]. We previously reported that the use of the combined antitumor effectof both gef and
apoptin genes on human colon tumoral cells improved the anticancer effect of the single-suicide
gene therapy. The synergistic anticancer effects of this double-suicide gene therapy overcome the
deficient apoptosis induction found in advanced or metastatic colon cancer. In addition, the synergistic
expression of both genes increased cell cytotoxicity by enhancing cell necrosis [16]. In the present
study, we analyze the mechanism by which death occurs when gef and apoptin genes are expressed
alone or combined.
2. Results
2.1. Morphological Findings
After 24 h treatment of control and transfected cells with Dox, RT-PCR was performed to detect gef
and/or apoptin expression. Figure 1 shows the expression of gef, apoptin, or both genes, respectively,
in the different cell lines (DLD1/Tet-On-gef, DLD1/Tet-On-apoptin and DLD1/Tet-On-gef -apoptin). No
expression of gef or apoptin was detected in the control cell line (DLD-1).
The morphological changes induced by the genes in control (DLD-1) and transduced cells
(DLD1/Tet-On-gef, DLD1/Tet-On-apoptin and DLD1/Tet-On-gef -apoptin) were analyzed using both
optical and scanning microscopy. Light microscopy showed that all the cell lines were characterized by
an epithelial morphology (Figure 2). We observed that the doses of Dox used to induce gene expression
have no effect on DLD-1 cell morphology (Figure 2A,B) and colonies developed concentrically to the
cells where their formation began. This finding was conditioned in part by the fact that dividing
cells rarely separated from the monolayer. However, all the cell lines transduced and induced with
doxycycline were characterized by the presence of cell shrinkage (Figure 2C–H). The size of these cells
was smaller, showed a dense cytoplasm, and their organelles were more tightly packed.
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Figure 1. (A) RT-PCR analysis shows expression of apoptin and gef genes. Lane 1: hyper ladder II; lane 
2: pRevTRE-apoptin (positive control); lane 3: DLD-1; lane 4: DLD1/apoptin; lane 5–6: 
DLD1/gef-apoptin; lane 10: DLD-1/gef; lane 11–12: DLD1/gef-apoptin; lane 13: DLD-1; lane 14: 
pRevTRE-gef (positive control). Average gene expression of gef (B) and apoptin (C) genes compared 
to the respective positive controls from left to right. pRevTRE-apoptin (positive control); DLD-1; 
DLD1/apoptin; DLD1/gef-apoptin; DLD-1/gef; DLD1/gef-apoptin; DLD-1; pRevTRE-gef (positive 
control). Data expressed as a mean ± SD from three independent experiments performed in duplicate 
(** p< 0.01 vs control). 
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Figure 1. (A) RT-PCR analysis shows expression of apoptin and gef genes. Lane 1: hyper ladder
II; lane 2: pRevTRE-apoptin (positive control); lane 3: DLD-1; lane 4: DLD1/apoptin; lane 5–6:
DLD1/gef-apoptin; lane 10: DLD-1/gef; lane 11–12: DLD1/gef-apoptin; lane 13: DLD-1; lane 14:
pRevTRE-gef (positive control). Average gene expression of gef (B) and apoptin (C) genes compared
to the respective positive controls from left to right. pRevTRE-apoptin (positive control); DLD-1;
DLD1/apoptin; DLD1/gef-apoptin; DLD-1/gef; DLD1/gef-apoptin; DLD-1; pRevTRE-gef (positive
control). Data expressed as a mean ± SD from three independent experiments performed in duplicate
(** p < 0.01 vs. control).
Scanning electron microscopy analysis of parental DLD-1 cells showed cells adhered to the surface
of the culture flask with the pr ence of elongated and/or m re or less polygo al forms with their
surface covered by multipl microvillous extensions (Figure 3A,B). The induction of the expression
f gef and/or apoptin genes in the DLD-1 cell line caused severe morphological changes. In fact,
most of the cells expressin both genes displayed initial signs of detachment of the substrate with
cellular elements that remained attached to the culture surface only by thi cyt plasmic processes
(Figure 3C,F,H). However, t e most striking featur was t e appearance in DLD1/T t-On-gef -apoptin
cells of many “pores” (Figure 3G,K–M) in the cytoplasmic membran that w re not detected in the
DLD-1 parental cells or in those transduced with onl apoptin. A smaller number of cells showed this
feature in the lin that expressed the gef gene (Figure 3E). Likewise, an important loss of filipodium
in gener l was also observed in the three transfected cell lines (Figure 3D,E,G,K–M) in comparison
to the control (Figure 3A,B). The presence of apoptotic bodies in all transduced and induced lines
(Figure 3C–E,G) was a characteristic.
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Figure 2. Phase contrast micrographs of parental DLD-1, DLD1/ Tet-On-gef, DLD1/ Tet-On-apoptin, 
and DLD1/ Tet-On-gef-apoptin cells after 48h of treatment with doxycycline (Scale bar = 100 μm). No 
differences were observed between DLD1cells (A) and cells treated with Dox (B). However, the lines 
transduced with gef and/or apoptin and induced with Dox were characterized by the presence of a 
group of smaller, rounded cells (more evident in D, F, H), less adhered to the culture bottle when 
compared to the parental cells. (C) DLD1/Tet-On-apoptin not induced with Dox; (D) 
DLD1/Tet-On-apoptin induced with Dox; (E) DLD1/Tet-On-gef not induced with Dox; (F) Tet-On-gef 
induced with Dox; (G) DLD1/Tet-On-gef-apoptin not induced with Dox; (H) DLD1/Tet-On-gef-apoptin 
induced with Dox. 
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with cellular elements that remained attached to the culture surface only by thin cytoplasmic 
processes (Figure 3C,F,H). However, the most striking feature was the appearance in 
DLD1/Tet-On-gef-apoptin cells of many “pores” (Figure 3G,K–M) in the cytoplasmic membrane that 
were not detected in the DLD-1 parental cells or in those transduced with only apoptin. A smaller 
number of cells showed this feature in the line that expressed the gef gene (Figure 3E). Likewise, an 
important loss of filipodium in general was also observed in the three transfected cell lines (Figure 
3D,E,G,K–M) in comparison to the control (Figure 3A,B). The presence of apoptotic bodies in all 
transduced and induced lines (Figure 3C–E,G) was a characteristic. 
Figure 2. Phase contrast micrographs of pare t l DLD-1, DLD1/ Tet-On-gef, DLD1/ Tet-On-apopti ,
and DLD1/ Tet-On-gef -apoptin cells after 48h of treatment with doxycycline (Scale bar = 100 µm). No
differences were observed between DLD1cells (A) and cells treated with Dox (B). However, the lines
transduced with gef and/or apoptin and induced with Dox were characterized by the presence of a group
of smaller, rounded cells (more evident in D, F, H), less adhered to the culture bottle when compared
to the pa ental cells. (C) DLD1/T t-On-apoptin not induced with Dox; (D) DLD1/Tet-On-apoptin
induced with Dox; (E) DLD1/Tet-On-gef not induced with Dox; (F) Tet-On-gef induced with Dox;
(G) DLD1/Tet-On-gef -apoptin not induced with Dox; (H) DLD1/Tet-On-gef -apoptin induced with Dox.
Confocal and flow cytometry analysis confirmed these observations. After Annexin V and IP
staining, and in comparison with control cells (Figure 4A,B), DLD1expressing gef or apoptin genes
showed cells in early and late apoptosis (Figure 4C–F). However, DLD1/Tet-On-gef -apoptin cells were
stained mainly as necrotic cells (Figure 4G,H).
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Figure 3. Scanning electron microscopic images of parental and transduced DLD-1 cells. DLD-1 cell 
line adhered to the culture surface with multiple filipodium (A). DLD1/Tet-On-gef cell line showed 
cells with several apoptotic bodies (red arrows) (B) and some cells have pores on their membrane 
surface (C). DLD1/Tet-On-apoptin cells showed signs of apoptosis with cytoplasmic membrane 
disruption, many apoptotic bodies, and clear signs of substrate detachment (D). 
DLD1/Tet-On-gef-apoptin cells, like the others, produced dead cells without filipodium and 
abundant apoptotic cells with the surface covered with apoptotic bodies (E). The most curious thing 
is that many more cells appeared with the surface full of pores of different sizes (F, G, and H). Red 
arrows signal apoptotic bodies and black arrows pores (Scale bar A, C, D, F, G, H = 1μm; Scale bar B = 
10μm; Scale bar E = 2μm). Quantification of filipodium number (I). Pore number (J). The height of 
each bar represents the number of pores with diameters in the interval between its lower and upper 
bounds on the x-axis. Pore diameters between 100–1500 nm can be observed in 
Figure 3. Scanning electron microsc pic images of parental nd transduced DLD-1 cells. DLD-1 cell line
adhered to the culture surface with multiple filipodium (A). DLD1/Tet-On-gef cell line showed cells
with several apoptotic bodies (red arrows) (B) and some cells have pores on their membrane surface
(C). DLD1/Tet-On-apoptin cells showed signs of apoptosis with cytoplasmic membrane disruption,
many apoptotic bodies, and clear signs of substrate detachment (D). DLD1/Tet-On-gef-apoptin cells,
like the others, produced dead cells without filipodium and abundant apoptotic cells with the surface
covered with apoptotic bodies (E). The most curious thing is that many more cells appeared with the
surface full of pores of different sizes (F–H). Red arrows signal apoptotic bodies and black arrows pores
(Scale bar A, C, D, F, G, H = 1 µm; Scale bar B = 10 µm; Scale bar E = 2 µm). Quantification of filipodium
number (I). Pore number (J). The height of each bar represents the number of pores with diameters
in the interval between its lower and upper bounds on the x-axis. Pore diameters between 100–1500
nm can be observed in DLD21/Tet-On-gef-apoptin cells. Quantifications were measured from the SEM
images (5 random photos) from three independent sample preparations. The data is represented as
mean ± S:D (** p < 0.01 vs. control and *** p < 0.001 vs. control).
Cancers 2019, 11, 264 6 of 18
Cancers 2019, 11, x 6 of 18 
 
DLD21/Tet-On-gef-apoptin cells. Quantifications were measured from the SEM images (5 random 
photos) from three independent sample preparations. The data is represented as mean ± S:D 
(**p<0.01 vs control and *** p< 0.001 vs control). 
Confocal and flow cytometry analysis confirmed these observations. After Annexin V and IP 
staining, and in comparison with control cells (Figure 4A,B), DLD1expressing gef or apoptin genes 
showed cells in early and late apoptosis (Figure 4C–F). However, DLD1/Tet-On-gef-apoptin cells 
were stained mainly as necrotic cells (Figure 4G,H). 
 
Figure 4. Confocal analysis and cell sorting quantification of DLD-1 (A,B), 
DLD1/Tet-On-gef(C,D),DLD1/Tet-On-apoptin (E,F), and DLD1/Tet-On-gef-apoptin (G,H) cells (Scale 
bar = 50μm). Cells were stained with annexin V-FITC and PI. Early apoptosis (Q4: green stain for 
annexin-FITC), late apoptosis (Q2: green stain for annexin-FITC in combination with red stain for PI), 
and necrosis (Q1: red stain for PI) can be observed; viable cells are not visible (Q3). In DLD1 
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Figure 4. Confocal analysis and cell sorting quantificatio of DLD-1 (A,B), DLD1/Tet-On-gef (C,D),
L 1/ apoptin (E,F), and DLD1/Tet-On-gef -apoptin (G,H) cells (Scale bar = 50 µm . Cells were
st ined with annexin V-FITC and PI. Early apoptosis (Q4: green stain for annexin-FITC), lat apoptosis
(Q2: green stain for annexin-FITC in combination with red stain for PI), and necros s (Q1: red stain for
PI) ca be observed; viable cells are not visible (Q3). In DLD1 xpressing gef or apoptin, cells in early
and late apoptosis are observed (C,E). DLD1/Tet-On-gef - poptin cells showed a high r proportion of
n crotic cells when compared o some ea ly and ate apopt tic cells (G,H).
2.2. Mechanism of Action of Gef and/or Apoptin
To identify the mechanism by which gef and/or apoptin genes induce cell death, caspases 3, 9 and
8, cytochrome c, bax, and p53 were studied. Protein collection was performed after 2 days of induction
with Dox, as described in material and methods.
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2.2.1. Pp53
We analyzed the expression of p53 under its phosphorylated form (Pp53). After normalization
and comparison to the relative value of the control (1), we observed a clear increase in Pp53 expression
in all the transduced lines but to different degrees (Figure 5A,A’). Thus, the band corresponding
to DLD1/Tet-On-gef had a value of 1.55, DLD1/Tet-On-apoptin 1.42, and DLD1/Tet-On-gef -apoptin
1.72, which indicates that p53 was phosphorylated to a greater degree when gef and apoptin were
expressed together.
2.2.2. Cytochrome c
The release of cytochrome c to the cytosol was manifested in an increase in the intensity of the
bands in the transduced and induced cell lines with respect to the corresponding control cell line
(Figure 5B,B’). Taking the value 1 as the normalized value of the control cell line, the normalized values
for the rest of the cell lines were: 2.4 for DLD1/Tet-On-gef cells, 3.41 for DLD1/Tet-On-apoptin, and
2.38 for DLD1/Tet-On-gef -apoptin cell line.
2.2.3. Bax
The activation of Bax was manifested as an increase in the intensity of the bands in the transduced
and induced cell lines in comparison to the band corresponding to the control cell line (Figure 5C,C’).
The normalized and relativized values with respect to the control for the lines DLD1/Tet-On-gef -apoptin,
DLD1/Tet-On-apoptin, and DLD1/Tet-On-gef were 7.4, 7.11, and 6.74, respectively.
2.2.4. Caspase 8
The normalized values corresponding to the expression of caspase 8 in the lines
DLD1/Tet-On-gef -apoptin, DLD1/Tet-On-apoptin, and DLD1/Tet-On-gef were 2.58, 1.81, and 1.66,
respectively (Figure 5D,D’). As a result of the combined effect of both genes, caspase 8 was expressed
to a greater degree in the cell lines infected by gef and apoptin together.
2.2.5. Caspase 9
The normalized values corresponding to the expression of pro-caspase 9 in the lines
DLD1/Tet-On-gef -apoptin, DLD1/Tet-On apoptin, and DLD1/Tet-On-gef were 1.32, 1.13, and 1.32,
respectively (Figure 5E,E’). There is therefore a greater expression in the transduced and induced lines
with Dox. The analysis of the activated form of caspase 9, using an antibody that detects its rupture, as
described in material and methods, confirmed the results objectifying a greater increase of expression
with respect to the control line. The normalized values were 4.31 for the line expressing both genes,
3.28 for the line with the apoptin gene, and 3.75 for the line with the gef gene.
2.2.6. Caspase 3
The expression of pro-caspase 3 and its activated form was studied (Figure 5F,F’). The
values obtained for the lines transduced and induced with Dox for pro-caspase 3 were 2.73 for
DLD1/Tet-On-gef -apoptin, 2.25 for DLD1/Tet-On-apoptin, and 3.66 for DLD1/Tet-On-gef. For the
activated form of caspase 3 the values were 2, 2.89, and 2.15, respectively. The expression of the genes
has therefore caused activation, in general terms, at least twice as much with caspase 3 as compared to
the control line.
After the analysis of the data, it is evident that there is an activation of mitochondrial apoptosis
(increased expression of Pp53, cytochrome c, Bax, and caspase 9), but we also observed an activation
of caspase 8 that would correspond to the extrinsic pathway of the apoptosis.
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Figure 5. Western blot analysis of (A) Pp53, (B) caspase 8, (C) cytochrome c, (D) Bax, (E) caspase 3,
(F) caspase 9. Line 1. Control DLD-1, line 2. DLD1/Tet-On-gef, line 3. DLD1/Tet-On-apoptin, line 4.
DLD1/Tet-On-gef -apoptin. Relative quantification of the western blot proteins normalized with β-actin
signal and relative to mock-treated cells (value 1) (A’, B’, C’, D’, E’, F’). Data expressed as a mean
±SD from three independent experiments performed in duplicate (* p < 0.05 vs. control, ** p < 0.01 vs.
control and *** p < 0.001 vs. control).
3. Discussion
The role of toxins in cancer treatment has been revealed due to their ability to kill tumoral cells
efficiently, making them a promising tool to be used as potential anticancer molecules. Among others,
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toxins encoded by bacteria (i.e., Corynebacterium or Pseudomonas species) or a plant belonging to the
ricin family have been successfully used to achieve cancer cell eradication [8–11]. Apoptin has been
shown to induce apoptosis in a selective manner in tumoral cells while not exerting a toxic effect in
normal cells. The gef gene from Escherichia coli shows an antiproliferative effect in different cancer
cell types (i.e., breast, melanoma, and colon cancer cells) [13,14,17]. Moreover, the use of combined
gene therapy improves the results obtained using single-gene therapies, enhancing the efficacy and
overcoming the shortcomings of this type of therapy. Thanks to these improved results, combination
gene therapy has become a first-line research field in gene therapy [7,18,19]. We recently demonstrated
that the combined transduction of gef and apoptin is able to target colon cancer cells, highlighting
the improved anticancer effect by using two direct suicide genes as a double-suicide gene therapy.
Simultaneous expression of gef and apoptin achieve a synergistic effect by decreasing tumoral cell
viability, enhancing necrosis, and increasing apoptosis induction. In our previous publication, results
showed an improved effect of the double-suicide gef and apoptin genes to decrease membrane potential
measured in mitochondria using a JC-1 probe after 2 and 6 days of doxycycline treatment compared to
single gef- or apoptin treated cells and control cells, suggesting apoptosis induction in colon tumoral
cells occurs via mitochondrial pathways [16]. In the present study, we have carried out morphological
studies and analyzed the protein profiles of several genes involved in different pathways of apoptosis
to try to establish the mechanism of action of gef and apoptin genes alone or combined.
Analysis using optical microscopy of the DLD-1 colon carcinoma cell line transduced with the
gef and/or apoptin genes and induced with Dox showed, in addition to small cells with an epithelial
morphology, which were similar to the parental cells, enshrined flat cells. These cells were smaller
in size, their cytoplasm was dense, and their organelles were more tightly packed. This cell group
was previously described as apoptotic cells by [20] in the B16F10 cell line of murine melanoma treated
with ganciclovir after its transfection by the simple herpes virus. Apoptosis has been extensively
studied and classified following morphological criteria [21]. This phenomenon is characterized by
membrane blistering, the adoption of a round shape by cells, condensation of cytoplasm and chromatin,
and the formation of apoptotic bodies, among other well-known phenomena [22]. In order to study
the effect of gef and apoptin expression on treated cells at morphological level, we carried out SEM
microscopy to obtain high-resolution micrographs of treated cells. SEM microscopy allowed us
to perform a thorough study of the cell surface. Our results provided interesting data regarding
the cell death induced by gef and/or apoptin. On the one hand, we have been able to observe
an important loss of filipodium in general in the three transfected cell lines in comparison to the
DLD-1 control line. In addition, other signs of cellular suicide induction were detected, including
the formation of apoptotic bodies, membrane blebbing, or cell contraction. Apoptotic bodies were
found in gef and apoptin transduced and induced cell lines but to a greater extent in the line that
co-expresses both genes. Apoptosis induction is related to cytoplasmatic and DNA contraction
and also with the apparition of membrane blebbing [19]. Also well-known is the involvement of
ROCK1 protein in cell membrane disorganization by caspase-mediated activation and its role in actin
stabilization, myosin phosphorylation, and the final coupling of actin-myosin cytoskeleton to the
plasma membrane. Through this mechanism of action, ROCK1 eventually leads to membrane blebbing
and cell contraction [23,24]. Similar morphological changes were observed in breast cancer due to gef
gene expression [25] and in lung and colon cancer cells after 5-fluorouracil-loaded calcium phosphate
nanoparticle treatment [26]. This data is in agreement with our previous publication in which we
analyzed, using flow cytometry with annexin V and propidium iodide and transmission electron
microscopy, the effect of gef and apoptin genes on the DLD-1 cell line.
However, the most striking feature was the appearance of many “pores” in the cytoplasmic
membrane, which were not detected, at any time, in the DLD-1 parental cells or in those transduced
only with apoptin, and in smaller measure in the line that expresses gef gene alone. It has been described
that in prokaryotic cells the expression of the gef gene leads to an efflux of intracellular Mg2+ and
an influx of periplasmic molecules by decreasing membrane potential [27]. This phenomenon finally
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induces cell death due to morphological changes [28]. Not with standing that gef gene mechanisms
of action have not been elucidated, SEM microscopy studies carried out in MS-36TG melanoma cells
expressing this gene showed the apparition of pore-like structures in the cell membrane, maybe related
to gef expression in this cancer cell line [15]. Interestingly, the number of pores observed through the
gef gene induction was much less than that observed with the co-expression of the gef and apoptin
genes. This suggests that although apoptin is not a pore-forming protein, it multiplies the pore-forming
capacity of the gef gene in eukaryotic cells, which would explain the synergistic antiproliferative effect
of both genes. In fact, we have previously demonstrated that simultaneous expression of both gef and
apoptin genes enhances cell cytotoxicity by cell necrosis induction [16]. Necrosis characterized by a
disorganization of the plasma membrane that finally leads to changes in osmolarity provoking cell
swelling and the release of cytosolic constituents into the extracellular space, initiating an inflammatory
response in some cases. Nevertheless, in necrosis the nucleus appears to be well preserved at the
beginning of the stage compared to apoptosis [29–32]. The excessive pore formation induced by gef
gene, and accentuated by apoptin, results in cell death by necrosis. Although cell membrane structure is
promptly disorganized in necrosis, in apoptosis it is initially kept intact in the early stages [30,33]. This
manner of death has also been described as a mechanism of action of several bacterial pore-forming
toxins such as Bacillus thuringiensis and Clostridium perfringens delta-toxin [34–36].
The effects of the gef and apoptin genes alone or combined to induce cell death were also
assessed using confocal microscopy with FITC-conjugated annexin V and PI stains. In the DLD-1
cell line expressing gef or apoptin, we detected cells in early and late apoptosis. The proportion of
DLD1/Tet-On-gef -apoptin cells under necrosis death was higher than cells under early or late apoptosis.
In the DLD-1 control cells, most of them were negative for both dyes, while a low number showed
apoptosis features. This is particularly important in colon cancer development and the formation of
metastases associated with apoptosis resistance [37]. Therefore, it is essential there is the presence of
an alternative mechanism of cell death to ensure the cytotoxic effect of gef and apoptin genes to target
cancer cells. Moreover, the increase in apoptosis and necrosis in uncontrolled proliferating cells was
described in several antitumor treatments such as combined treatment with the monoclonal antibody
IMC-C225 and the topoisomerase I irinotecan inhibitor (CPT-11) in DLD-1 cell line [38] and inhibition
of long non-coding RNA PVT1 in human acute erythroleukemia cells [39].
Apoptosis can occur mainly through two different pathways: the extrinsic (by transmembrane
receptors) and the intrinsic (mitochondrial). The extrinsic pathway requires trans-membrane receptors
called “Death Receptors” (DR) and ligands that interact with such receptors. The receptors belong
to the superfamily of tumor necrosis factor (TNF) receptors. It includes Fas (CD95), TNFR-I and
II, p75NTR, DR-3, and TRAIL (DR-4 and DR-5). They have an intracellular domain (DD) and an
extracellular domain rich in cysteines. Adapter proteins such as RIP, FADD, RAIDD, or TRADD
bind to the intracellular domains to form the signaling complex that induces cell death. Once the
complex is formed, initiating caspases 8 and 10are activated, and finally, the activation caspases 3, 6,
and 7 are activated, which generates the signal to the endonucleases that will culminate in cellular
apoptosis [40]. Bcl-2 family proteins play a key role in the mitochondrial cell death pathway by
disrupting the mitochondrial membrane potential and the release of apoptogenic factors, such as
cytochrome c from mitochondria, in the cytosol [41]. The Bcl-2 family consists of members that can
be divided according to their activity into two groups: anti-apoptotic proteins such as Bcl-2, Bcl-x,
BAG, Bcl-w, and Bcl-XL and pro-apoptotic proteins such as Bax, Bcl-xL, Bcl-xS, Bax, Bik, Bak, Blk,
Bad,Bcl-10,and BimandBid [42].
Cell death induction exerted by gef or apoptin expression has been related to apoptosis intrinsic
pathway [16,43]. We have previously demonstrated that simultaneous expression of both genes or each
one alone induces the alteration of the mitochondrial membrane structure, suggesting the importance
of the mitochondrial pathway in apoptosis mediation. In addition to the alterations of the membrane
and DNA and protein degradation, the fundamental characteristic of apoptosis is mainly the activation
of caspases, a family of proteins composed of cysteine proteases [44]. The activation of these proteins
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plays a key role in cytoskeleton and nuclear scaffold degradation by activation of other proteins.
Additional to this process, they stimulate DNAse and enhance the degradation of the DNA [45]. In the
present study, we carried out a western blot analysis of the caspases 3, 9, and 8, cytochrome c, bax, and
p53 to dilucidate the mechanism of action of both genes in DLD-1 colon cancer cells. Data showed
an increase inPp53 expression of cytochrome c, Bax, and caspases 9 after 48h of the induction of
gene expression. This data supports the hypothesis that gef and apoptin are still capable of activating
the mechanism of cell destruction mediated by the mitochondrial lesion. Thus, the activation of
pro-apoptotic proteins induces pore formation in the mitochondrial outer membrane and the release
of proteins such as the serine protease HtrA2/Omi cytochrome-c, Smac/DIABLO, or cytochrome-c
by the diminution of the mitochondrial transmembrane potential. In the apoptosome formation, the
cytochrome c joins to procaspase-9 and the adapter molecule Apaf-1 to later activate procaspase-3 by
hydrolysis and trigger the last stage of apoptosis [46]. That the activation of caspase-mediated apoptotic
pathways is a strategy to induce the destruction of tumor cells is confirmed by the experiments of Jang
and collaborators which demonstrate that transfection of ANT1 triggers apoptosis induction in the
MDA-MB-231breast cancer cell line by inactivating NF-κB and increasing the expression of Bax [47].
The induction of ANT1 apoptosis was accompanied by the alteration of the mitochondrial membrane
potential, the release of cytochrome c, and the activation of caspases 9 and 3. Other suicide genes, such
as cry1Ab [48] and gef [49], suggest pore formation and activation of Protein Kinase A (PKA).
However, we have also observed a clear activation of caspase 8 when the gef and apoptin genes
are expressed alone or in combination. This data suggests that apoptosis mediated by the expression
of gef and apoptin in the DLD-1 line also involves molecules of the extrinsic pathway of apoptosis [42].
The execution phase is the endpoint where both the intrinsic and extrinsic pathways converge and
is considered the final stage of apoptosis. The last stage of apoptosis is characterized by the activation
of caspases which activates proteases and endonucleases that leads to cytoskeletal protein and nuclear
material degradation. In this context, caspase-3 plays a key role as effector of the pathway by cleaving
different substrates including plasma membranes, cytoskeletal and nuclear proteins, among others
(alpha foldrin and NuMA proteins) [50]. Our results support the hypothesis that the convergence of
both intrinsic and extrinsic pathways can induce the activation of caspase-3. Caspase-3 plays a key
role in the executioner caspase pathway and is activated by any of the initiator caspases (caspase-8,
caspase-9, or caspase-10).
Several authors have shown that the overlap and integration of the two pathways occurs at the
Bid level, a proapoptotic gene belonging to the Bcl-2 family. The proapoptotic activity of Bid is greatly
increased by its caspase-8-mediatedrupture and translocation to the mitochondria, where it promotes
the activation of the caspase-3, the formation of the apoptosome, and the release of the cytochrome
c [18,51]. ICAD caspase-3-mediated cleavage promotes the rupture of the complex CAD and it is
inhibitor ICAD (CAD-ICAD complex) in apoptotic cells, while in proliferating cells the integrity of the
structure is maintained [52]. Finally, CAD provokes chromosomal DNA degradation and chromatin
condensation leading to the formation of apoptotic bodies by cytoskeletal disintegration [41,53–55].
The potential mechanism of action of gef/apoptin genes in DLD-1 tumor cancer cell line is summarized
in Figure 6.
Excessive pore formation induced by the gef gene in both mitochondrial and cytoplasmic
membrane leads to target cell death by necrosis due to alteration of mitochondrial activity as a
result of a drastic reduction of ATP and potassium levels. At lower concentrations (separate gef
or apoptin expression), death may occur in a programmed way via apoptosis in its two pathways.
However, co-expression of both genes subjects the target cell to an excessive load of toxins that implies
the appearance of uncontrolled cell death or necrosis. This necrosis could correspond to the secondary
post-apoptotic necrosis that, according to Silva (2010), is the natural result of the complete apoptotic
program [56]. Recent studies have described that when there is a large number of apoptotic cells
in vitro or when the phagocytic system of the organism is overwhelmed, the apoptotic cells progress
to a stage of secondary necrosis in which they progressively lose their structural integrity and release
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parts of their cytoplasm due to the permeabilization of its plasma membrane [57,58]. In this context, the
same phenomenon was observed in MCF-7 breast cancer cells after exposure to the gef gene combined
with new synthesized cyclic and acyclic O,N-acetals compounds [59]. Moreover, Chen et al. observed
that the infectious pancreatic necrosis virus induces post-apoptotic necrotic cell death through loss of
mitochondrial membrane potential (MMP) followed by caspase-3 activation in CHSE-214 cells [60].
Furthermore, there are several studies that suggest the existence of common regulators between
necrosis and apoptosis [58]. Hitomi and collaborators showed that TNFα activates signaling mediated
by RIP 1 kinase for the induction of subsequent genes that influence either necrosis or apoptosis [61].
In our system, we believe that the combination of genes gef and apoptin induces a clear increase in
post-apoptotic necrotic cell death which could facilitates intratumoral immune responses, as has been
shown previously in breast cancer [62], and could be a valuable tool in the design of new antitumor
strategies focused on the enhancement of the immune response against cancer cell death [63].Cancers 2019, 11, x 12 of 18 
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4. Material and Methods
4.1. Cell Lines
DLD-1 human colorectal carcinoma cells (ATCC® CCL-221™, Manassas, VA, USA) were obtained
from the Immunology Service, Virgen de las Nieves Hospital (Granada, Spain). These types of cells
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were originally isolated from an adult male with a Dukes’ type C colorectal adenocarcinoma where the
cancer had spread to at least one lymph node in the area close to the bowel [64].
The DLD1/Tet-On-gef, DLD1/Tet-On-apoptin, and DLD1/Tet-On-gef -apoptin cell lines, and gef
and/or apoptin-expressing colorectal carcinoma cell lines controlled using a Tet-on system and induced
using doxycycline (Dox) were derivates from DLD-1 cells following methodology previously described
by us [16].
DLD-1 cells were grown at 37 ◦C, 5% CO2 in Dulbecco’s modified Eagle medium (DMEM)
(Sigma, St. Louis, MO, USA) in the presence of 10% heat-inactivated fetal bovine serum (FBS) (Sigma),
1% HEPES buffer, 40 mg/L gentamicin, 2% L-glutamine, 2.7% sodium bicarbonate and 500 mg/L
ampicillin. Transfected DLD1 cell line with gef, apoptin, or both genes were cultured in the same
conditions and medium described above supplemented with hygromycin B (0.4 mg/mL, Sigma) and
doxycycline 0.2 mg/mL.
4.2. RNA Extraction Protocol and RT-PCR Analysis
Extraction of total RNA from DLD-1, DLD1/Tet-On-gef, DLD1/Tet-On-apoptin, and
DLD1/Tet-On-gef -apoptin cells was carried out using the RNA extraction kit (Promega Corporation,
Madison, WI, USA) after 24 h of induction with doxycycline (0.2 mg/mL). For the reverse-transcription
of the RNA into cDNA, one microgram of RNA from each cell line was mixed with the cDNA synthesis
kit (Promega). Reverse transcription (RT) was done as follows: each tube contained 0.4 µM of random
hexamers, 1 µM of each deoxynucleotide triphosphate (dNTP), 2.0 mM MgCl2, 24 units of avian
myeloblastosis virus reverse transcriptase (Promega), and 40 U RNasin (Promega) in a total volume
of 20 µLof RT buffer. After incubation at 42 ◦C for 20 min and 94 ◦C for 5 min (Linus Autocycler 32,
CulteK S.L., Madrid, Spain), samples were resuspended in 80 µL H2O with diethylpyrocarbonate.
PCRs were performed using 5 µLof the RT products with the following primers: Gef 1:
50 GAAGCAGCATAAGGCGATG 30 and Gef 2: 50 CCGCCGTTGCTCTTACTC 30; Apop 1: 50
GAACGCTCTCCAAGAAGATAC 30; and Apop 2: 50 ATTACCACTACTCCCAGCCG 30. PCR (gef
94 ◦C for 5 min, 51 ◦C for 1 min, and 72 ◦C for 1 min; apoptin: 48.9 ◦C for 5 min, 51 ◦C for 1 min, and
72 ◦C for 1 min) was carried out for 32 cycles, with a final elongation step of 72 ◦C for 10 min. For the
product visualization, 10 µL of the reaction was loaded on a 2% agarose gel, detected using ethidium
bromide staining, and the image was photographed under ultraviolet light. The integrity of the RNA
was assessed by amplification of β-actin. The analysis of the intensity of the signal was carried out
using the Quantity One program. The values of each band were relativized with respect to the control
sample, to which the value 1 was assigned.
4.3. Scanning Electron Microscopy
The cells were grown on sterile 10 × 10 cm coverslips and then were fixed with 2.5%
glutaraldehyde in 0.05 M cacodylate buffer, pH 7.4, containing CaCl2 1.24 mM, KCl 0.7 M and
MgCl2 1.24 mM for 2 h at 40 ◦C with. After fixation, cells were washed with cold phosphate buffered
salineand treated with 1% tannic acid in 0.1 M cacodylate buffer for 1 h at 4 ◦C. Then, the preparation
was washed again briefly in the same buffer. After centrifugation in 1% agarose, cells were post-fixed
using OsO4. Using amyl acetate/ethanolthe fixated cells were dehydrated and finally dried and
coated with gold. Images were acquired using a Hitachi S-800 scanning electron microscope (SEM)
(Hitachi, Tokyo, Japan). Counting of filipodium number and number of pores per cell were performed
using ImageJ with quantification for each cell type from 5 random photos from three independent
sample preparations.
4.4. Confocal Microscopy and Flow Cytometry for Apoptosis Detection
Cells were seeded at a confluence of 5 × 103 cells/well in an8-well Labtek chamber slide. After
24 h, they were treated with Dox for 48 h. After that, culture medium was discarded and cells washed
with cold phosphate buffered saline and incubated with both annexin V-FITC and propidium iodide
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solution for 15 min at room temperature. Finally, cells were washed with binding buffer and were
processed using flow cytometry for its quantification. In addition, a sample was taken and preserved
using mounting medium and cover slips before confocal microscopic imaging. Images were acquired
using a Leica SP2 Confocal Microscope. Counting of filipodium number and number of pores per cell
were performed using ImageJ with quantification for each cell type from 5 random photos from three
independent sample preparations.
4.5. Protein Analysis
To study protein expression differences after 48 h of Dox treatment we performed a western
blot. Cells seeded on 6-well plates were lysed using Laemmli buffer and the lisate was loaded in
the electrophoresis gel, electroblotted onto nitrocellulose membranes and submerged in phosphate
buffered saline containing 5%non-fat dried milk in agitation for 1h at room temperature. To detect
protein expression, the following primary antibodies were used: phosphorylated p53 (p-p53 (FP3.2):
sc- 51690, Santa Cruz Biotechnology, (Santa Cruz Biotechnology, Santa Cruz, CA, USA), caspase
8 (caspase-8 (8CSP03): sc-56070, Santa Cruz Biotechnology), caspase 3, 1:1000 in 5% non-fat dry
milk in TBS (Cell Signaling, Beverly, MA, USA), caspase 9 (caspase-9 p35 (A-): sc- 133109, Santa
Cruz Biotechnology), cytochrome-c (cytochrome c (7H8): sc- 13560, Santa Cruz Biotechnology),
Bax, (Bax (N-20): sc- 493, Santa Cruz Biotechnology) and β-actin (A2228, Sigma). Secondary
antibodies used included anti-rabbit IgG peroxidase conjugate (Sigma, A0545) and anti-mouse IgG
peroxidase conjugate (Sigma, A9044). Protein–antibody complexes were made visible using enhanced
chemiluminescence (ECL, Bonus, Amersham, Little Chalfont, UK) with the program IMAGE READER
LAS-4000 in a LAS-4000 imaging system.
The analysis of the intensity of the signal was carried out using the Quantity One program.
The values of each band were normalized by dividing them by the value of their β-actin, and they
were relativized with respect to the control sample to which the value 1 was assigned.
4.6. Statistical Analysis
The data is expressed as means ± standard deviation (SD). The statistical significance of
differences between the two groups was determined using Student’s t test. A p value of 0.05 or
less was considered to be statistically significant.
5. Conclusions
The data obtained in this study demonstrates for the first time that that co-expression of gef
and apoptin genes induces apoptosis, which occurs not only via intrinsic but also extrinsic signaling
pathways. Both gef and apoptin genes induce an important increase of caspase 8 and 9 that converges
at caspase 3 that acts as an “executor” of apoptosis. In fact, caspases 8 and 9 reached higher levels
after the co-expression of the gef and apoptin genes than when expressed separately. This data could
explain, at molecular level, the synergistic effect observed through the combination of gef and apoptin
genes. These results are of interest because apoptosis in advanced or metastatic colon cancer may
be deficient. Moreover, co-expression of gef and apoptin genes induces an increase in post-apoptotic
necrotic cell death that could be a valuable tool in the design of new antitumor strategies focused on
the enhancement of the immune response against cancer cell death.
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